StonvexLoading…
StonvexStonvexStonvexCore line items from HIND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 |
|---|---|---|---|---|
Revenue | $2.35M | $1.11M | $8.01M | $6.20M |
Operating Income | $-4.97M | $-199.00K | $-1.01M | $-750.33K |
Net Income | $-1.16M | $-293.97K | $-1.45M | $-1.14M |
EPS (Diluted) | $-1.85 | $-761.59 | $-6001.39 | $-2955.71 |
Total Assets | $9.03M | $1.44M | $1.38M | $1.28M |
Total Liabilities | $3.20M | $5.25M | $5.77M | $4.13M |
Cash & Equivalents | $4.12M | $2.52M | $101.90K | $743.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 2.62M | 133.08K | 0 | 704.70K |